Form D · Biotechnology
Jabez Biosciences, Inc.
Cranberry Twp., PA · CIK 0002038185
Offering snapshot reported Mar 26, 2026 · SEC filing
- Reported sold
- $31.2K Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Jun 11, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2026 | Initial | $31,200 | No comparison | 8 | SEC filing |
| Oct 28, 2025 | Amendment | $250,510 | -$2,299,490vs Oct 21, 2025 | 3 | SEC filing |
| Oct 21, 2025 | Initial | $1,326,500 | No comparison | 18 | SEC filing |
| Oct 21, 2025 | Initial | $2,550,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-577807
Source: Form D, filed Mar 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Cassidy | Director |
| Brian Cogley | Director, Executive |
| Tamara Jovonovich | Director, Executive, Promoter |
| Robert Lewis | Director, Executive, Promoter |
| Martin Lewis | Director |
| Michael Lewis | Promoter |
| David Mehalick | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2009 Mackenzie Suite 100
Cranberry Twp., PA, 16066
Cranberry Twp., PA, 16066